Abstract:Objective To investigate coagulation,anti-coagulation and fibrinolysis function of chronic schistosomiasis,terminal schistosomiasis,chronic hepatitis B and liver cirrhosis patients. Methods The plasma samples of 50 chronic schistosomiasis and terminal schistosomiasis patients from antischistosomiaisis station ,50 chronic hepatitis B and liver cirrhosis patients from the first affiliated hospital of Nanchang university were collected and 50 healthy plasma as controls were also collected. The plasma coagu-lation function (PT,APTT,TT,Fg),anti-coagulation function (AT-III、PC、PS) and fibrinolysis function (PLG) were tested and an-alyzed. Results 1.Compared with healthy controls: ⑴the chronic schistosomiasis group exhibit significant differences in the anti-coagulation function (AT-III、PC、PS) but no significant difference in the coagulation function (PT,APTT,TT and Fg);the level of D-Dimer in chronic schistosomiasis group was significantly different,but the level of plasminogen was not significantly different.⑵the levels of PT,TT,Fg in the terminal schistosomiasis group were significantly different,but the level of APTT was not differ-ent;the terminal schistosomiasis group exhibit significant differences in the anti-coagulation and fibrinolysis function. ⑶The chronic hepatitis B and liver cirrhosis group exhibit significant differences in the coagulation ,anti-coagulation and fibrinolysis function. 2.There were significant differences in the level of PT,TT,AT-Ⅲ,PC,D-Dimer and plasminogen between the chronic schistosomiasis and terminal schistosomiasis group and no differences in the level of APTT ,Fg and PS. 3.There were significant differences in the coagulation,anti-coagulation function and the level of plasminogen between the chronic schistosomiasis and chronic hepatitis B group,and no difference was found in the level of D-Dimer. 4.There were significant differences in the coagula-tion(except the level of TT),anti-coagulation and fibrinolysis function between the terminal schistosomiasis and liver cirrhosis group. 5.There were significant differences in the level of PT,APTT and D-Dimer and anti-coagulation function between the chronic hepatitis B and liver cirrhosis group,and there was no difference in the level of TT,Fg and plasminogen. Conclusion The chronic schistosomiasis,terminal schistosomiasis,chronic hepatitis B and liver cirrhosis patients present some disorders in coagula-tion,anti-coagulation and fibrinolysis function. The detection of coagulation,anti-coagulation and fibrinolysis indexes can help to monitor the haemostatic and coagulation function of the chronic schistosomiasis,terminal schistosomiasis,chronic hepatitis B and liver cirrhosis patients.

The Relationship Between Serum Insulin-Like Growth Factor-1 and Liver Function in Patients with Schistosomal Liver Fibrosis

Serum CHI3L1 As a Biomarker for Non-invasive Diagnosis of Liver Fibrosis.

Expressions of IL-18,IL-12 and IFN-γ in Chronic Severe Hepatitis Patients and Treatment with Artificial Liver Support System

Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with Schistosoma japonicum

Study on the Relationship Between Insulin Growth Factor 1 and Liver Fibrosis in Patients with Chronic Hepatitis C with Type 2 Diabetes Mellitus.

Determination of Serum Levels of YKL-40 and Hyaluronic Acid in Patients with Hepatic Fibrosis Due to Schistosomiasis Japonica and Appraisal of Their Clinical Value.

IgG persistence showed weak clinical aspects in chronic schistosomiasis patients

Studies on risk factors for liver fibrosis of schistosomiasis japonica]

The Effect of Hyperinsulinemia in Patients with Cirrhosis on Serum Leptin Levels

Determination of Serum Fibrosis Indexes in Patients with Chronic Hepatitis and Its Significance

Effect of Anluohuaxian Tablet Combined with Γ-Ifn on Schistosomal Liver Fibrosis

High level of C3 is associated with Th2 immune response and liver fibrosis in patients with schistosomiasis

Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis

The Dynamics of Hepatic Fibrosis Related to Schistosomiasis and Its Risk Factors in a Cohort of China

Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality

A-250 Evaluation of Liver Fibrosis in Schistosomiasis Mansoni Using the ELF (Enhanced Liver Fibrosis) Score

Study on the Expression of Hepatic Procollagen Mrna in Schistosomiasis with Liver Fibrosis

Hepatic schistosomiasis as a determining factor in the development of hepatic granulomas and liver fibrosis: a review of the current literature

The study of coagulation,anti-coagulation and fibrinolysis function of chronic schistosomiasis,terminal schistosomiasis, chronic hepatitis B and liver cirrhosis patients

In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis

Endothelin receptors promote schistosomiasis-induced hepatic fibrosis via splenic B cells